Clinical Trials Browser

Terminated × Carcinoma, Renal Cell × Imatinib Mesylate × Clear all

NCT00323791 2009-12-11

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms